Ma Ming, Jin Guo-Jiang, Yun Ke, Mu Run-Qing, Zhao Min, Yu Xiao-Ou, Wang Shuo, Shang Hong
Department of Laboratory Medicine, The First Hospital of China Medical University, Nanjing Street No. 155, Heping District, Shenyang, 110000, People's Republic of China.
Tumour Biol. 2015 Feb;36(2):807-14. doi: 10.1007/s13277-014-2653-y. Epub 2014 Oct 9.
Inflammatory/immune cells have the power of infiltrating almost all human solid tumors and influencing all stages of carcinogenesis because of their stimulation of various cytokine subsets. This study aims to determine the correlation of single nucleotide polymorphisms in the IL-17F gene and the risk of colorectal cancer (CRC). One thousand patients diagnosed with CRC and a control group of 354 healthy controls were involved. Peripheral blood samples were collected. The PCR-RFLP method was used to detect the 7383A>G (rs2397084) and 7488T>C (rs763780) in the IL-17F gene. Statistical analyses were conducted with version 12.0 STATA statistical software. We found that the allele model suggested that patients carrying C allele were 1.67 times more likely to develop CRC than healthy controls (odds ratio (OR) = 1.67, 95% confidence interval (CI) = 1.22-2.27, P = 0.001). Similarly, the homozygous and dominant models also revealed that the minor IL-17F 7488C allele conferred an increased CRC risk compared to the major T allele among our study participants (CC vs. TT: OR = 4.15, 95% CI = 1.26-13.36, P = 0.011; TC+CC vs. TT: OR = 1.46, 95% CI = 1.04-2.05, P = 0.027). However, all genetic models indicated that the IL-17F 7383A>G (rs2397084) polymorphism was not associated with CRC risk (all P > 0.05). The results of this study indicate that the 7488T>C (rs763780) in the IL-17F gene may be correlated with increased risk of CRC.
炎症/免疫细胞由于能刺激各种细胞因子亚群,几乎具有浸润所有人类实体瘤并影响癌症发生各个阶段的能力。本研究旨在确定白细胞介素-17F(IL-17F)基因单核苷酸多态性与结直肠癌(CRC)风险之间的相关性。研究纳入了1000例经诊断患有CRC的患者以及354例健康对照组成的对照组。采集外周血样本。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法检测IL-17F基因中的7383A>G(rs2397084)和7488T>C(rs763780)。使用STATA 12.0统计软件进行统计分析。我们发现,等位基因模型显示,携带C等位基因的患者患CRC的可能性是健康对照的1.67倍(优势比(OR)=1.67,95%置信区间(CI)=1.22 - 2.27,P = 0.001)。同样,纯合子和显性模型也显示,在我们的研究参与者中,与主要的T等位基因相比,次要的IL-17F 7488C等位基因会增加患CRC的风险(CC与TT:OR = 4.15,95% CI = 1.26 - 13.36,P = 0.011;TC + CC与TT:OR = 1.46,95% CI = 1.04 - 2.05,P = 0.027)。然而,所有遗传模型均表明IL-17F 7383A>G(rs2397084)多态性与CRC风险无关(所有P > 0.05)。本研究结果表明,IL-17F基因中的7488T>C(rs763780)可能与CRC风险增加相关。